PSTV stock

Plus Therapeutics Inc (PSTV) receives a Buy rating from D. Boral Capital
Roman Campbell
Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22 ...

Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22 ...